Global Prescription Digital Therapeutics (DTx) Market Research Insights, Latest Trends, Major Players Profile, Size Estimation, COVID-19 Impact and Future Trends By 2027
DBMR has added a new report titled Global Prescription Digital Therapeutics (DTx) Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. This report covers the present scenario and the growth prospects of the global market and includes a discussion of the key vendors operating in the market. It intends to supply an entire 360-degree perspective of this market concerning cutting edge technology, key advancement, drivers and restraints and prospective trends with impact analysis. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risk and entry barriers. This Global Prescription Digital Therapeutics (DTx) Market report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.
This Global Prescription Digital Therapeutics (DTx) Market report provides a valuable source of insightful for business strategists and competitive analysis of the global market. It provides industry overview with the growth analysis and futuristic cost. This Global Prescription Digital Therapeutics (DTx) Market research report guides you to overcome the upcoming obstacles in the business. Various Analytic tools like SWOT analysis, Porters five force analysis, PESTLE Analysis are utilized to gain the relevant information of the market. In the end, Report provides a comprehensive data which enhances the understanding, scope and application of the report.
Global Prescription Digital Therapeutics (DTx) Market is rising gradually with a healthy CAGR of 23.35% in the forecast period of 2019-2026. Growing prevalence of cancer worldwide and expanding the application of CRISPR technology by innovative research from the different academic organizations are the key factors for market growth. Few of the major competitors currently working in the global prescription digital therapeutics (DTx) market are Better Therapeutics, LLC, BigHealth, Headspace Inc, Kaia Health, Xealth, Solera Network, F. Hoffmann-La Roche Ltd, ResMed, Pear Therapeutics, Inc, Omada Health, Inc., WellDoc, Inc, Voluntis, Teva Pharmaceutical Industries Ltd, 2Morrow Inc, SAMSUNG among others.
Get Sample Report + All Related Graphs & Charts @
Unlock new opportunities in Prescription Digital Therapeutics (DTx) Market; the latest release from Data Bridge Market Research highlights the key market trends significant to the growth prospects, Let us know if any specific players or list of players needs to consider to gain better insights.
Segmentation:-
Global Prescription Digital Therapeutics (DTx) Market By Diseases (Type 2 Diabetes Prevention and Management, Substance Abuse, Asthma, Insomnia and Others), Application (Preventative Care and Wellness, Diagnosis, Treatment Decision and Others), Therapies (Medication Augmentation, Medication Replacement and Others), End- Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026
Competitive Analysis:
Global prescription digital therapeutics (DTx) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global CRISPR gene-editing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Definition:
Prescription digital therapeutics is a novel treatment approach that allows software applications to directly treat serious disease. It is designed in such way that it delivers evidence-based treatment anytime, anywhere and even providing clinicians with real-time data on patient progress.
According to the statistics published in Pear Therapeutics, Inc, One in every three adults are suffering from the symptoms of insomnia which contribute up to 30 million adults are living with chronic insomnia in the United States. This growing incidence of cases globally and increase regulatory approvals are acts as market drivers.
Market Drivers
- High prevalence of disease worldwide is driving the growth of this market
- High regulatory approvals for digital therapeutics by regulatory authorities is also acting as a driver for the market growth
- Promising demonstration of clinical outcomes is boosting the market growth
- High demand due to their High cost effectiveness can also act as a market driver
Market Restraints
- Unaffordability of digital therapeutics is restricting the growth for the market
- Limited access to novel treatment options for conditions that previously have been untreated or undertreated by traditional medications and therapies which acts as a market restraint
- Lack of healthcare budget in some middle-income countries is also hampering the market growth
Grab Your Report at an Impressive 30% Discount! Please click Here@https://www.databridgemarketresearch.com/request-a-discount/global-prescription-digital-therapeutics-dtx-market
The current trend pertaining to the demand supply and sales together with the recent developments have been given here to provide an exhaustive picture of this market. It also allows voluntarily accessible affordable reports of the research that is the end result of the personalized research carried by the internal team of professionals.
To comprehend Global Prescription Digital Therapeutics (DTx) market dynamics in the world mainly, the worldwide Prescription Digital Therapeutics (DTx) market is analyzed across major global regions.
- North America: United States, Canada, and Mexico.
- South & Central America: Argentina, Chile, and Brazil.
- Middle East & Africa: Saudi Arabia, UAE, Turkey, Egypt and South Africa.
- Europe: UK, France, Italy, Germany, Spain, and Russia.
- Asia-Pacific: India, China, Japan, South Korea, Indonesia, Singapore, and Australia.
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Key Developments in the Market:
- In July 2019, Pear Therapeutics, Inc filed marketing authorization application from the FDA for Somryst, a prescription digital therapeutic (PDT) the treatment of chronic insomnia and depression in adults. If approved, it could become third FDA-authorized PDT indication, representing newer innovation for patients and physicians
- In June 2018, Headspace Inc has launched a company Headspace Health which will focus on the creation of a new prescription meditation application by end of 2020. This creation of the new company is the most significant milestone towards healthcare industries to help for treating a range of chronic diseases
Reasons to Purchase this Report
- Current and future of global prescription digital therapeutics (DTx) market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- CDN Newswire
